Table 1.
ADn = 119 | DLBn = 67 | p Valuea | |
---|---|---|---|
Age (SD) | 75.4 (7.7) | 75.8 (7.3) | 0.986 |
Sex, men/women | 34/85 | 36/31 | 0.001 |
Education, y (SD) | 9.7 (2.9) | 9.6 (2.8) | 0.820 |
MMSE (SD) | 23.7 (2.4) | 23.2 (3.1) | 0.340 |
Duration of symptoms, y (SD) | 1.9 (1.8) | 2.5 (2.1) | 0.041 |
Depression (SD) | 1.9 (2.5) | 2.4 (2.8) | 0.198 |
CDR global, mean (SD) | 0.8 (0.3) | 1.0 (0.5) | 0.559 |
Dementia medication at FU1, y/n | 59/60 | 29/38 | 0.409 |
aDifferences between AD and DLB groups were analyzed using the Mann–Whitney U-test and Pearson chi-square.
AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; MMSE, Mini-Metal Status Examination; CDR, Clinical Dementia Rating; FU1, follow up 1; y, years; y/n, yes/no.